Correlation Between Abcellera Biologics and Weyco

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Abcellera Biologics and Weyco at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcellera Biologics and Weyco into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abcellera Biologics and Weyco Group, you can compare the effects of market volatilities on Abcellera Biologics and Weyco and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcellera Biologics with a short position of Weyco. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcellera Biologics and Weyco.

Diversification Opportunities for Abcellera Biologics and Weyco

0.4
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Abcellera and Weyco is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Abcellera Biologics and Weyco Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Weyco Group and Abcellera Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcellera Biologics are associated (or correlated) with Weyco. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Weyco Group has no effect on the direction of Abcellera Biologics i.e., Abcellera Biologics and Weyco go up and down completely randomly.

Pair Corralation between Abcellera Biologics and Weyco

Given the investment horizon of 90 days Abcellera Biologics is expected to generate 1.63 times more return on investment than Weyco. However, Abcellera Biologics is 1.63 times more volatile than Weyco Group. It trades about 0.03 of its potential returns per unit of risk. Weyco Group is currently generating about -0.22 per unit of risk. If you would invest  292.00  in Abcellera Biologics on September 14, 2024 and sell it today you would earn a total of  3.00  from holding Abcellera Biologics or generate 1.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Abcellera Biologics  vs.  Weyco Group

 Performance 
       Timeline  
Abcellera Biologics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Abcellera Biologics disclosed solid returns over the last few months and may actually be approaching a breakup point.
Weyco Group 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Weyco Group are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Weyco is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Abcellera Biologics and Weyco Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Abcellera Biologics and Weyco

The main advantage of trading using opposite Abcellera Biologics and Weyco positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcellera Biologics position performs unexpectedly, Weyco can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Weyco will offset losses from the drop in Weyco's long position.
The idea behind Abcellera Biologics and Weyco Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume